These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23278862)

  • 21. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?
    Specht MC; Fey JV; Borgen PI; Cody HS
    J Am Coll Surg; 2005 Jan; 200(1):10-4. PubMed ID: 15631914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sentinel lymph node biopsy is successful and accurate in male breast carcinoma.
    Flynn LW; Park J; Patil SM; Cody HS; Port ER
    J Am Coll Surg; 2008 Apr; 206(4):616-21. PubMed ID: 18387465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.
    Harisinghani MG; Barentsz J; Hahn PF; Deserno WM; Tabatabaei S; van de Kaa CH; de la Rosette J; Weissleder R
    N Engl J Med; 2003 Jun; 348(25):2491-9. PubMed ID: 12815134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sentinel lymph node biopsy in breast cancer].
    Shen K; Nirmal L; Han Q; Wu J; Lu J; Zhang J; Liu G; Shao Z; Shen Z
    Zhonghua Wai Ke Za Zhi; 2002 May; 40(5):347-50. PubMed ID: 12133338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of metastatic breast cancer in non-sentinel lymph nodes based on metalloprotease-1 expression by the sentinel lymph node.
    Eiró N; González LO; Atienza S; González-Quintana JM; Beridze N; Fernandez-Garcia B; Pérez-Fernández R; García-Caballero T; Schneider J; Vizoso FJ
    Eur J Cancer; 2013 Mar; 49(5):1009-17. PubMed ID: 23063352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
    Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
    Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Number of lymph nodes removed in sentinel lymph node-negative breast cancer patients is significantly related to patient age and tumor size: a new source of bias in morbidity assessment?
    Port ER; Patil S; Stempel M; Morrow M; Cody HS
    Cancer; 2010 Apr; 116(8):1987-91. PubMed ID: 20151427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy.
    Rydén L; Chebil G; Sjöström L; Pawlowski R; Jönsson PE
    Eur J Surg Oncol; 2007 Feb; 33(1):33-8. PubMed ID: 17174513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The optimal management of the axillae of patients with microinvasive breast cancer in the sentinel lymph node era.
    Gray RJ; Mulheron B; Pockaj BA; Degnim A; Smith SL
    Am J Surg; 2007 Dec; 194(6):845-8; discussion 848-9. PubMed ID: 18005782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.
    Nos C; Harding-MacKean C; Fréneaux P; Trie A; Falcou MC; Sastre-Garau X; Clough KB
    Br J Surg; 2003 Nov; 90(11):1354-60. PubMed ID: 14598414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional magnetic resonance imaging using iron oxide particles in characterizing head and neck adenopathy.
    Hoffman HT; Quets J; Toshiaki T; Funk GF; McCulloch TM; Graham SM; Robinson RA; Schuster ME; Yuh WT
    Laryngoscope; 2000 Sep; 110(9):1425-30. PubMed ID: 10983936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated with involvement of four or more axillary nodes for sentinel lymph node-positive patients.
    Katz A; Niemierko A; Gage I; Evans S; Shaffer M; Smith FP; Taghian A; Magnant C
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):40-4. PubMed ID: 16488555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Lymphoscintigraphy in sentinel lymph node biopsy of breast cancer].
    Zhang J; Shen K; Nirmal L; Liu G; Wu J; Zhang Y; Du H; Pan Z; Shao Z; Shen Z
    Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):616-8. PubMed ID: 12667340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy.
    Kargozaran H; Shah M; Li Y; Beckett L; Gandour-Edwards R; Schneider PD; Khatri VP
    J Surg Res; 2007 Nov; 143(1):126-9. PubMed ID: 17950081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting the likelihood of additional nodal metastases in breast carcinoma patients with positive sentinel node biopsy.
    Mustać E; Matusan-Ilijas K; Marijić B; Smokvina M; Jonjić N
    Int J Surg Pathol; 2010 Feb; 18(1):36-41. PubMed ID: 19448065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intra-operative ex vivo photoacoustic nodal staging in a rat model using a clinical superparamagnetic iron oxide nanoparticle dispersion.
    Grootendorst DJ; Fratila RM; Visscher M; Haken BT; van Wezel RJ; Rottenberg S; Steenbergen W; Manohar S; Ruers TJ
    J Biophotonics; 2013 Jun; 6(6-7):493-504. PubMed ID: 23341267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between the area of high-signal intensity on SPIO-enhanced MR imaging and the pathologic size of sentinel node metastases in breast cancer patients with positive sentinel nodes.
    Motomura K; Izumi T; Tateishi S; Sumino H; Noguchi A; Horinouchi T; Nakanishi K
    BMC Med Imaging; 2013 Sep; 13():32. PubMed ID: 24028426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sentinel lymph node mapping with superparamagnetic iron oxide for melanoma: a pilot study in healthy participants to establish an optimal MRI workflow protocol.
    Aldenhoven L; Frotscher C; Körver-Steeman R; Martens MH; Kuburic D; Janssen A; Beets GL; van Bastelaar J
    BMC Cancer; 2022 Oct; 22(1):1062. PubMed ID: 36241982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.